THANK YOU FOR SUBSCRIBING
Arterys partners with healthcare providers to enable digital, cloud-based services and accurate diagnostic tools for better cancer care.
FREMONT, CA: Arterys, the developer of one of the first internet platforms for medical imaging, unveils its products and partnerships. Arterys aims to serve radiologists with faster and more accurate diagnostic tools.
"Arterys is at a pivotal point in time in which we are really uniquely positioned to scale our solutions," said Arterys CEO John Axerio-Cilies. "We're excited to introduce new partnerships and product updates that will support physicians in delivering personalized, data-driven patient care."
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Arterys is expanding its operations through multiple partnerships advancing healthcare services, and integrating digital solutions. Tempus acquired Arterys and is collaborating with Amazon Web Service (AWS) to develop Amazon HealthLake Imaging that can store, share, and analyze medical images at a petabyte scale. Arterys aims to enhance medical services, diagnostic tools, and treatment methods like Lung AI. The Lung AI application utilizes artificial intelligence to process lung CT scans and track abnormalities like lung nodules. Advanced capabilities provide physicians with improved diagnostic solutions' speed, efficiency, and accuracy.
Partnerships with services like HealthLake Imaging and DeepLook Medical are streamlining operations. HealthLake Imaging services connect users to the cloud while accessing medical imaging data. AI and machine learning (ML) capabilities optimize imaging data collection by reducing physical infrastructures that reduce operational costs. Healthcare providers can redirect resources to more pressing healthcare services to meet rising demands and provide quality healthcare services.
The collaboration with DeepLook Medical effectively removes inaccuracies and human errors from oncological diagnosis and treatment procedures. Arterys acquired DL Precise segmentation tool accurately characterizes tumors and assesses the tumor's growth rate and its shrinkage. Initially developed by DeepLook, DL Precise analyzes tumor trends after therapy and tracks its stages to effectively aid treatment plans.
Arterys’s partnership with InferVision integrates AI-driven oncology solutions in cancer detection, tumor segmentation, and follow-up treatments. Automated diagnostic tools enable greater reporting efficiency.
More in News